Randomized Orbital Floor Fracture Trial Pits Iliac Crest Graft Against Titanium Mesh

A randomized clinical trial at Suez Canal University is directly testing two very different ways to rebuild the orbital floor after fracture: autogenous iliac crest bone grafting and titanium mesh fixation. The study focuses on a problem that is easy to underestimate until the anatomy fails—an injured orbital floor can allow the eye contents to settle downward, producing enophthalmos, diplopia, and restricted motility when the bony support is not restored with precision.

This is not a large trial, but it is surgically relevant. Twenty adults with isolated orbital floor fractures were enrolled, and the protocol assigns patients in equal numbers to the two reconstruction strategies. The comparison is centered on a practical question in maxillofacial trauma: whether the biologic advantages of autologous bone outweigh the convenience and structural predictability of an alloplastic mesh in a defect where both contour and volume restoration matter.

Why Orbital Reconstruction Demands Exact Volume Control

Orbital floor repair is not simply about covering a defect. The operation is trying to restore the orbital cavity to its pre-injury geometry so the globe sits in the correct position and the extraocular muscles are not tethered by herniated tissue or scar. Even small inaccuracies in reconstruction can translate into clinically visible asymmetry, diplopia, or persistent restriction of gaze.

The protocol makes that anatomic goal explicit through its primary endpoint: change in orbital volume measured by computed tomography before and immediately after reconstruction. Three-dimensional segmentation software is used to calculate the bony orbital cavity, with the orbital rim serving as the anterior boundary and the anterior margin of the optic canal as the posterior boundary. In orbital trauma, that type of volumetric assessment is especially useful because it captures the structural consequence of repair rather than relying on inspection alone.

One-sentence reality check: a millimeter of residual orbital expansion can still leave a patient with a sunken eye.

Two Materials, Two Surgical Philosophies

The iliac crest arm uses an autogenous cortical graft harvested from the medial aspect of the crest through a 4 to 6 cm incision. The bone is shaped and placed into the orbital defect after transcutaneous exposure, subperiosteal dissection, and reduction of the herniated orbital contents. Autograft remains attractive because living bone can integrate, remodel, and eventually consolidate with the recipient site, offering a biologic repair rather than a purely structural patch.

Titanium mesh follows a different logic. The alloplastic implant provides immediate contour support, can be customized to the defect, and avoids the donor-site morbidity that comes with harvesting bone. In orbital surgery, mesh can be appealing because the orbit is a confined three-dimensional space where a stable scaffold may matter as much as tissue incorporation. The tradeoff is familiar to every reconstructive surgeon: foreign material can provide reliable framework, but it cannot behave like native bone.

The operation itself is standardized across both groups. All patients underwent general anesthesia, transcutaneous access to the inferior orbital rim and floor, reduction of orbital fat and tissue, intraoperative forced duction testing to verify ocular mobility, and standard closure with tarsorrhaphy. That level of procedural uniformity helps isolate the material comparison from avoidable technical variation.

Pain, Bone Healing, and the Donor-Site Question

The study does not stop at radiology. Secondary outcomes include postoperative pain, assessed with the visual analogue scale on days 1, 7, and 14, plus serial evaluation of bone formation by CT at 1 month and 6 months. Extraocular movement limitation is tracked clinically, and the investigators are watching for wound dehiscence, infection, graft or implant rejection, diplopia, and enophthalmos through 6 months of follow-up.

Those outcomes matter because the choice between bone graft and mesh is never made on orbit shape alone. Iliac crest harvest introduces a second wound and a second pain generator, which can be clinically decisive in a patient already recovering from facial trauma. Titanium mesh removes the donor site but shifts the balance toward a permanent implanted material, where long-term structural behavior and tissue response become part of the calculation.

The postoperative regimen is standardized as well: amoxicillin/clavulanic acid for one week, anti-inflammatory treatment for one week, and as-needed analgesia recorded on selected postoperative days. That consistency matters when pain and infection are among the outcomes under surveillance, because it reduces the chance that a medication difference obscures the effect of the reconstructive material itself.

A Small Cohort, but a Focused Surgical Comparison

The study includes adults aged 23 to 50 years with isolated orbital floor fractures confirmed by CT. Patients with osteoporosis, bone-resorbing disease, uncontrolled diabetes, or other major medical compromise were excluded, which makes the cohort cleaner for evaluating bone healing but also narrows how broadly the findings can be applied. The trial is open-label, parallel-group, randomized, and interventional, with recruitment completed and no results posted yet.

The narrow inclusion criteria are a strength and a limitation at the same time. They reduce biologic noise in a study of bony repair, yet they also mean the findings will speak most directly to otherwise healthy adults with isolated fractures rather than to older patients, patients with systemic disease, or more complex orbital injuries. In a procedure as anatomy-dependent as orbital floor reconstruction, those exclusions are clinically sensible, because compromised bone biology can overwhelm the material comparison.

One sentence stands out in practical terms: the trial is asking whether the best reconstruction is the one that heals like bone or the one that behaves like a precisely engineered scaffold.

What This Trial Could Clarify for Maxillofacial Surgeons

For surgeons, the central issue is not abstract biomaterials theory. It is whether one method better restores the orbital floor while minimizing persistent diplopia, postoperative volume error, and the need for later correction. If the iliac crest graft demonstrates stronger radiographic integration and more favorable orbital volume restoration, it would support the continued role of autologous reconstruction in selected cases. If titanium mesh provides equivalent anatomic correction with less pain or fewer complications, the appeal of a donor-site-free approach becomes harder to ignore.

The study is anchored at the Faculty of Dentistry at Suez Canal University in Ismailia, Egypt, and was registered under ClinicalTrials.gov identifier NCT07941934. Because the record lists no posted results, the current value of the trial lies in its design and endpoints rather than in any reported outcome. The most relevant unanswered question is whether the biologic advantage of iliac crest bone is enough to justify donor-site harvest when a titanium scaffold can restore the same orbital contour with less surgical burden.


Reporting by Dr. Aishwarya N., MBBS for Medicine World Foundation, with additional data provided by ClinicalTrials.gov.
PRIMARY CLINICAL EVIDENCE & REGISTRY DATA